Bridging the gaps in (18)F PET tracer development
As compared to the drug discovery process, the development of new 18F PET tracers lacks a well-established pipeline that advances compounds from academic research to candidacy for (pre)clinical imaging. In order to bridge the gaps between methodological advances and clinical success, we must rethink...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2016
|